首页 产品目录 分子砌块 按官能团 醇类 (S)-4-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)-3-(7-methyl-5-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one

(S)-4-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)-3-(7-methyl-5-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one

(S)-4-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)-3-(7-methyl-5-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
25mg 95% 询价
- +
50mg 95% 询价
- +
100mg 95% 询价
- +
250mg 95% 询价
- +
1g 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

468740-43-4

英文名称

(S)-4-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)-3-(7-methyl-5-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one

别名

4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone;CS-469;BMS 536924;BMS536924;BMS-536924;Insulin-like Growth Factor-1 Receptor Inhibitor;4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(4-morpholinyl)-1H-benzimidazol-2-yl]- 2(1H)-pyridinone;CS-0117;HY-10262

标准英文名

(S)-4-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)-3-(7-methyl-5-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one

分子式

C25H26ClN5O3

分子量

479.97

精确分子量

479.17

SMILES

CC1=C2NC(C3=C(NC[C@@H](O)C4=CC=CC(Cl)=C4)C=CNC3=O)=NC2=CC(N2CCOCC2)=C1

标准SMILES

CC1C=C(C=C2N=C(NC2=1)C1C(=O)NC=CC=1NC[C@@H](O)C1C=C(Cl)C=CC=1)N1CCOCC1

用途

BMS-536924 is an ATP-competitive inhibitor of the insulin-like growth factor-1 receptor (IGF-1R) with an IC50 of 100 nM; it exhibits moderate inhibitory activity against FAK, MEK, and Lck, but minimal activity against Akt1 and MAPK1/2. It suppresses IGF-1R signaling, inhibits ligand-induced phosphorylation of ERK1/2, GSK3β, and Akt, and blocks both IGF-I-stimulated and basal IGF-1R activity in MCF10A cells. BMS-536924 demonstrates antiproliferative effects in various cancer cell lines, including TC32, HT1080/S, SK-LMS-1, H513, CTR, Rh41, and Rh36, and induces apoptosis by upregulating PDCD4 expression and promoting cleavage of PARP and caspase-3. In vivo, it shows potent antitumor activity in IGF-1R-driven Sal tumor models and unmodified Colo205 human colon cancer xenografts upon oral administration (100–300 mg/kg, once or twice daily). It significantly inhibits tumor growth in nude mice bearing TGBC-1TKB cell-derived xenografts and reduces CD8-IGF-1R-MCF10A xenograft tumor volume by 76% after two weeks of treatment (100 mg/kg). BMS-536924 also enhances insulin secretion in response to glucose challenge without causing significant toxicity, as evidenced by no adverse effects on body weight or glucose levels in treated mice.

InChIKey

ZWVZORIKUNOTCS-OAQYLSRUSA-N

安全信息

SureRoute逆合成路线

1.  468740-43-4 逆合成路线 1

—
—
—
—
ACKNWD773
468740-43-4
来源: SureRoute

2.  468740-43-4 逆合成路线 2

—
—
—
—
ACKNWD773
468740-43-4
来源: SureRoute

3.  468740-43-4 逆合成路线 3

—
—
ACKNWD773
468740-43-4
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手